MIRA INFORM REPORT

 

 

Report Date :

15.02.2007

 

IDENTIFICATION DETAILS

 

Name :

ASSOCIATED CAPSULES PRIVATE LIMITED

 

 

Registered Office :

131, Kandivli Industrial Estate, Kandivli (West), Mumbai- 400067, Maharashtra, India

 

 

Country:

India

 

 

Financials (as on):

31.03.2005

 

 

Date of Incorporation :

13.07.1961

 

 

Com. Reg. No.:

11-12061

 

 

CIN No.:

[Company Identification No.]

U24239MH1961PTC012061

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

MUMA18885G

 

 

PAN No.:

[Permanent Account No.]

AAACA4769K

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturers and Sellers of hard gelatin capsule shells I.P coating on various substracts and lamination printed / unprinted films / sheets of PVC, PP and other materials.

 

RATING & COMMENTS

 

MIRA’s Rating :

A

 

RATING

STATUS

PROPOSED CREDIT LINE

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

 

Maximum Credit Limit :

USD 7000000

 

 

Status :

Good

 

 

Payment Behaviour :

Regular

 

 

Litigation :

Clear

 

 

Comments :

Subject is a well established and reputed company engaged in manufacturing and marketing/exporting of hard gelatine capsule shells, HPMC Capsule Shells, Coated/Laminated Siltted Firms and Cold Form Blisters and PVC films.

 

The company has been making good progress consistently. Directors are well experienced and very resourceful industrialists. Trade relations are reported as fair. Payments are usually made as per commitments.

 

It can be considered good for business dealings at usual trade terms and conditions.

 

LOCATIONS

 

Registered Office :

131, Kandivli Industrial Estate, Kandivli (West), Mumbai- 400067, Maharashtra, India

Tel. No.:

91-22-28682010 (9 Lines)

Fax No.:

91-22-28686152/28682514

E-Mail :

acg@bom5.vsnl.net.in

sunny.pj@acg-world.com

Website :

http://www.acgworld.com

Area :

4933 sq.mtr

Location :

Owned

 

 

Corporate Office :

10th Floor, Dalamal House, Nariman Point, Mumbai – 400 021,  Maharashtra, India

Tel. No.:

91-22-2287 2557/58/59/2288 0461/2/3 /22856666

Fax No.:

91-22-22872560

E-Mail :

acg@bom5.vsnl.net.in

krishnan.ky@acg-world.com

info@acg-world.com

 

 

Factory 1 :

131, Kandivli Industrial Estate, Kandivli (West), Mumbai – 400 067, Maharashtra, India

Tel. No. :

91-22-2868 2010

Fax No. :

91-22-2868 6152 / 2868 2514

E-mail. :

sales.acpl@acg-world.com

 

 

Factory 2 :

Village Shindewadi, Shirwal, Taluka Khandala, District Satara, Maharashtra, India

 


 

DIRECTORS

 

Name :

Mr. Ajit Singh (Foreign)

Designation :

Managing Director

Address:

131, Kandivli Industrial Estate, Kandivli  (West), Mumbai – 400 067, Maharashtra

Tel. No.  :  91-22-28682010

Fax No.  :  91-22-28682514

E-Mail:  acg@bom5.vsnl.net.in

 

 

Name :

Mr. Jasjit Singh (Foreign)

Designation :

Director

Date of Joining:

17/08/1964

Address:

131, Kandivli Industrial Estate, Kandivli  (West), Mumbai – 400 067, Maharashtra

Tel. No.  :  91-22-28682010

Fax No.  :  91-22-28682514

E-Mail:  acg@bom5.vsnl.net.in

 

 

Name :

Mrs. Vijaya Kuverba

Designation :

Director

Date of Joining:

13/09/1963

Address:

Ben Nevis, Bhulabhai Desai Road, Mumbai – 400 026, Maharashtra

 

 

 

KEY EXECUTIVES

 

Name :

Mr. Navin C. Asthana

Designation :

Company Secretary

 

MAJOR SHAREHOLDERS

 

Names of Shareholders

 

No. of Shares

 

 

 

Mr. Jasjit Singh

 

 

Mr.Ajit Singh

 

180

Mrs.Vijaya K. Kuverba

 

18,000

Mr. Jasjit Singh

 

 

Mr. Ajit Singh

 

1,20,114

Mr. Ajit Singh

 

16,902

Ashagadh Trading Investment and Financial Company

 

1,09,890

Rajasthan Capsules Private Limited

 

1,79,100

Non Trade Exports Private Limited

 

1,78,200

Surya Capsules Private Limited

 

1,77,300

 

BUSINESS DETAILS

 

Line of Business :

Manufacturers and Sellers of hard gelatin capsule shells I.P coating on various substracts and lamination printed / unprinted films / sheets of PVC, PP and other materials.

 

 

Products with ITC Code :

Product Description

ITC No.

 

 

Hard Gelatin Capsule Shells I.P.

96020003

Cellulose Capsules

20

Coating on various substracts and lamination – printed / unprinted

3920

Films / Sheets of PVC / PORTUGAL and other materials

392041

 

 

Imports from :

Europe

 

 

Terms :

 

Purchasing :

L/C and Credit terms

 

PRODUCTION STATUS

 

Particulars

Unit

Installed Capacity

 

 

 

Hard Gelatin Capsule Shells IP

Million Nos.

23800

HPMC Cellulose Capsule Shells IP

Million Nos.

300

Coated/Laminated & Slitted Films/ & Cold Form Blisters & PVC Films

Tonnes

11400

 

GENERAL INFORMATION

 

No. of Employees :

Around 1800

 

 

Bankers :

v      Standard Chartered Grindlays Bank Limited, ORD SA, 90, M. G. Road, Mumbai – 400 001, India 

v      Bank of India

v      State Bank of India, Virani Industrial Estate, Goregaon (East), Mumbai – 400 050, India 

 

 

Facilities :

[figures are in Rupees Millions)

Facility

31.03.2004

 

SECURED LOANS

 

 

Working Capital from Banks

Secured by hypothecation of stock in trade, book debts and second charge by way of equitable mortgage over land and building in favour of Consortium of Bankers. (in respect of Dahnau Unit the working capital from bank is secured by hypothecation of stock of raw material, packing materials, stores and spares, work in progress and finished goods.)

71.071

 

 

UNSECURED LOANS

 

 

From Others

16.460

Short term loans and Advances

 

From directors

85.470

From others

55.042

 

 

Other Loans

 

Deferred Sales Tax Incentive

(Due with in a year Rs. NIL, Previous year Rs. NIL) [Under the package scheme of incentives of the government of maharashtra.]

62.723

 

 

TOTAL

290.766

 

 

 

Banking Relations :

Good

 

 

Auditors :

A. J. Shah & Company

Chartered Accountants

 

 

Associates :

v      Aries Components Manufacturing Private Limited

v      Associated Traders & Manufacturers

v      Ashagadh Trading Investment and Finance Company

v      Bombay Suburban Finance & Investment Company Private Limited

v      Nontrade Exports Private Limited

v      Kandivli Finance Company Private Limited

v      Navrang Investment and Trading Company Private Limited

v      Nepean Holdings Private Limited

 

v      Pam Glatt Pharma Technologies Private Limited

Profile: PAM-Glatt was set up as a joint venture between ACG Worldwide and Glatt GmbH, Germany, pioneers of fluid bed technology, for the manufacture of world class FBE fluid bed processors in India.

The FBE fluid bed processors provide cost-effective solutions for standard applications in the pharmaceutical, chemical, food and feed industries. It is versatile over a wide range of processes including batch granulation, agglomeration of powder products, top spray film coating and batch drying of moist substances.

The plant at Mumbai conforms to all GMP and safety standards worldwide, including those specific to dust explosion. A quick action stop valve has been introduced to guarantee optimum protection of people, equipment and the working environment.

 

v      Pam Pac Machines Private Limited

PAM-PAC also represents IWKA in India for an advanced range of high speed machines for blister packing, cartoning, tube filling and specially customized machinery.

 

v      Pharmagenets

v      Surya Capsules Private Limited

v      Western India Pharmaceutical Services Private Limited

v      Katol Land Development & Trading Company Private Limited

v      Reflections

v      Universal Capsules Limited

v      Nontrade Exports Private Limited

v      Rajasthan Capsules Private Limited

v      Universal Capsules Private Limited

Profile: It is an active member and US subsidiary of ACG Worldwide. It is one of the few organizations in the world to offer end-to-end solutions in solid dosage systems. It manufactures from empty gelatine capsules to natural vegetarian capsules; from capsule-filling machines to packaging films and blister packing machines.

 

Subject represents ACG Worldwide in Indonesia and surrounding countries, to market their entire range of empty hard gelatin capsules, capsule filling and sorting machines, pharmaceutical grade PVC and PVdC coated PVC films, and blister packaging machines.

Known for its reliable supplies of high quality capsules, low rejection levels, guaranteed machine performance and its unswerving dedication to fight spurious drug manufacturers, the company has established itself in the region as one of the leading suppliers of solid dosage delivery formulations.

The company has had a long-term relationship with local ethical pharmaceutical manufacturers as well as herbal manufacturers (JAMU) and even provides for Apotek and pharmacies. Leading pharmaceutical giants including PT Sanbe, PT Soho, PT Pharos, PT Medion, PT Indopharma, PT Zenith and many others form a part of the company's vast clientele.

Besides having received certificates of approval from HALAL, Malaysia and the ISO 9002 Certification, the company is expecting the Indonesian MUI Certification as well.

 

v      ACL Packaging Private Limited

 

Profile: A pioneer in introducing PVdC coated PVC films in India, the Associated Capsule Limited - Packaging Films Division provides the complete range of high quality barrier packaging films for blister packing. It is the only unit in India, which manufactures rigid substrate PVC films as well as moisture barrier PVdC coatings and laminations on the film, ensuring total control on quality.

 

Aluminium Cold Forming Blister Foil and pinhole-free lidding foil is also marketed in collaboration with VAW, Germany. For extremely hygroscopic formulations, a W&H laminator manufactures Triplex PVC/PE/PVdC films. PVC/ACLAR films are laminated in collaboration with world leader Honeywell, USA. Aluminium Cold Forming Blister Foil is also marketed in collaboration with VAW, Germany.


The state-of-the-art plant at Shirwal maintains high GMP standards for the pharmaceutical and food industries. ACL continuously introduces the latest technology in high barrier films at its Quality Assurance laboratory for the testing and development of packaging materials. Lab services are also offered to customers to test and conduct trials of their products with various barrier films. Stringent quality controls and personal attention to customers needs are responsible for the company's number one position in the industry.

 

 

Group Companies:

Ø       Ajas Agrovat Foundation

Ø       Amil Enterprises

Ø       Associated Traders & Manufacturers

Ø       Ajas Components Private Limited

Ø       Ascap Holdings

Ø       Bulk Buyers

Ø       Capsulabs

Ø       Custom Capsules Private Limited

Ø       Centercops

Ø       Dahanu Corporation

Ø       Emell Audhyowgik Samshodhan Nigam

Ø       Extra Hands

Ø       Jasjit Singh (HUF)

Ø       Universal Capsules Private Limited

Ø       Aries Components Manufacturing & Company

Ø       MNT Will Trust

Ø       Laxmi Devi Deity Trust

Ø       Lord Krishna Deity Trust

Ø       Lord Shiv Shankar Deity Trust

Ø       Nepean Holding Private Limited

Ø       Pam Pharmaceutical & Allied Machinery Company Private Limited

Ø       Pam Glatt Pharma Technologies Private Limited

Ø       Pam Pac Machines Private Limited

Ø       Pharmagents

Ø       Universal Capsules (L.l.C.)

Ø       Reflection

Ø       Sardar Daljit Singh (HUF)

Ø       Scitech Centre

Ø       PT. Universal Capsules Indonesia

Ø       Universal Capsules Philippines Inc.

Ø       Fmepean Holding

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

24,00,000

Equity Shares

Rs 5/- each

Rs 12.000

Millions

30000

12% Non Cummulative Redeemable Preference Shares

Rs. 100/- each

Rs. 3.000 Millions

 

Total:

 

Rs. 15.000 Millions

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

1138276

Equity Shares

Rs 5/- each

Rs 5.691 Millions

21701

12% Non Cummulative Redeemable Preference Shares

Rs. 100/- each

Rs. 2.170 Millions

 

Total:

 

Rs. 7.861 Millions

 


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2005

31.03.2004

31.03.2003

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

7.861

7.861

9.846

2] Reserves & Surplus

1798.248

1586.797

652.064

NETWORTH

1806.109

1594.658

661.910

 

 

 

 

LOAN FUNDS

 

 

 

1] Secured Loans

71.071

35.138

39.752

2] Unsecured Loans

219.695

150.653

246.712

TOTAL BORROWING

290.766

185.791

286.464

DEFERRED TAX LIABILITIES

44.585

57.330

39.799

 

 

 

 

TOTAL

2141.460

1837.779

988.173

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

592.454

509.075

333.379

Capital work-in-progress

34.120

54.078

5.047

 

 

 

 

INVESTMENTS

77.641

86.419

32.247

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

Inventories

186.971

185.546

147.523

Sundry Debtors

788.442

821.177

349.011

Cash & Bank Balances

40.834

104.209

17.179

Loans & Advances

639.327

431.353

230.982

Total Current Assets

1655.574

1542.285

744.695

Less: CURRENT LIABILITIES & PROVISIONS

 

 

 

Current Liabilities

167.710

320.231

104.200

Provisions

59.009

33.847

22.995

Total Current Liabilities

226.719

354.078

127.195

Net Current Assets

1428.855

1188.207

      617.500

 

 

 

 

MISCELLANEOUS EXPENSES

8.390

0.000

0.000

 

 

 

 

TOTAL

2141.460

1837.779

988.173


PROFIT & LOSS ACCOUNT

 

PARTICULARS

 

31.03.2005

31.03.2004

31.03.2003

Sales Turnover [including other income]

2608.650

2561.074

1261.127

 

 

 

 

Profit/(Loss) Before Tax

347.506

566.998

188.315

Provision for Taxation

129.756

165.778

45.282

Profit/(Loss) After Tax

217.750

401.220

143.033

 

 

 

 

Export Value

870.370

919.050

385.960

 

 

 

 

Import Value

208.48

186.010

125.510

 

 

 

 

Total Expenditures

2261.144

1994.075

1072.812

 

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2005

31.03.2004

31.03.2003

PAT / Total Income
(%)

8.35

15.67

11.34

 
 

 

 

 

Net Profit Margin

(PBT/Sales)

(%)

13.32

22.14

14.93

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

14.73

25.87

16.88

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.19

0.36

0.28

 

 

 

 

 

Debt Equity Ratio

(Total Liability/Networth)

 

0.29

0.34

1.68

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

7.30

4.36

5.85

 

LOCAL AGENCY FURTHER INFORMATION

 

HISTORY

 

Subject was incorporated on 13th July 1961 at Mumbai in Maharashtra under the name and style of Associated Capsules Limited having Company Registration Number 12061.

 

The company has converted into the private limited liability company.

 

Performance

 

The operations of both the Capsules Division and the PVC/VDC Division during the year were encouraging and reflected an improvement over the previous year. The company has done well in Exports to USA during the year.

 


Corporate Restructuring:

 

Keeping in view the changes taking place in the global environment, the aging top management and the imminent changes of guard in the next few years (specially in view of limited number of family members), it was necessary to build in simplicity of holdings, flexibility and attractiveness in terms of a large internationally viable business unit not having internal competition. This necessitated undertaking of corporate restructuring exercise for consolidating capsules manufacturing operations and simplying the corporate structure. Also the need to successfully compete in global arena necessitated cutting down of duplicate costs, standardizing processes and products, maximizing synergy and repositioning the group as a serious global player.

 

During the year the company received court approvals sanctioning the scheme of arrangements for demerger of capsules manufacturing division of Universal Capsuls Private Limited in to the company and amalgamation of Ashagadh Trading Investment & Finance company, Navrang Investment & Trading Company Private Limited, Non Trade Exports Private Limited, Rajasthan Capsules Private Limited, Surya Capsules Private Limited, Aries Components Manufacturing Private Limited and Western India Pharmaceuticals Services Private Limited (Seven Transferor Companies) with the company with retrospective effect from 01.04.2003. The financial statement of the demerged capsules manufacturing business and seven transferor companies have been incorporated in the current financial statement of the company. This includes recasting the opening balances of the company to incorporate the figures of the capsules manufacturing business and seven transferor companies.

 

Merger

 

The company has filed an application with the High Court for merger of ACPL with seven other small Finance Companies and the Merger of Capsules business demerged out of UCPL. This application is filed on 11th August 2004 and the amalgamation date was 31st March, 2003 and Demerger Date was 1st April, 2003.

 

Common Group Logo

 

The company has finalised the Common Group Logo and has introduced the same across the Group Cos., to build up the company Image and Identify to had synergy benefits in the market both at Domestic and International Market.

 

It is in trade terms with:-

 

v      Ameija Enterprises

v      AVS Enterprises

v      Avadhoot Paper Products

v      ID Technologies Ambika Engineering Works

v      Multifilm Plastics

v      Protocontrol

v      Primepack Containrs

v      Suyash Industries

v      Udit Packaging

v      Lead Edger Papers

v      ABM Enterprises

v      Asian Electronics Limited

v      Udit Packaging Private Limited 

v      M-Con Engineering Systems Private Limited

v      Roha Dyechem Private Limited

v      Colorcon Asia Private Limited

v      Anuradha Plas & Tex Industries

v      Parekh Packaging

v      Neelikon Food Dyes & Chemicals

v      Narayan Packaging

v      Sejal Plastics

v      Sterling Gelatin

 

 

Fixed Assets:

 

Land, Buildings, Plant & Machinery, Vehicles, Furniture / Fixtures, Speed Boat & Office Equipments.

 

As Per Website

 

Profile

 

ACG Worldwide is serving the pharmaceutical industry for four decades. They are one of the largest manufacturers of hard gelatin capsules in the world. Comprising of ten group companies including subsidiaries in USA and Indonesia, ACG Worldwide has manpower strength of over 2700.

 

ACG Worldwide provides world-class technology, the complete package of solutions - from empty capsules to granulation and coating, to capsule filling, packaging films, blister packing and carton packing. Their products are exported to over 65 countries and they have installed over 12,000 machines worldwide. They have set high standards of quality, with most of their group companies acquiring major international quality certifications.

 

ACG Worldwide is committed to Research and Development for continuous delivery of innovative solutions. Their research teams continuously strive to develop innovative technology to offer their customers the competitive edge.

 

SciTech Centre, the group's 50,000 sq. ft. R & D Center in the heart of Mumbai, is a government recognized research institution. Over the last 25 years, it has been actively engaged in research in the areas of dosage form development including controlled release, pharmaceutical engineering, veterinary and agricultural research, particularly in delivery systems.

 

Awards and Recognitions

 

ACG Worldwide has become a name to reckon with in the pharmaceutical industry in a time span of forty years due to a team effort. Various organizations have conferred various awards & recognitions upon us. ACG Worldwide is headed by distinguished personalities & any recognition received by them is an award for ACG equally.

 

ACG Worldwide received the OPPI Best vendor Company award for their contribution towards saving a good amount of foreign exchange for India.

 

UK's topmost capsule manufacturing company Leiner Group visited the Kandivali plant to purchase its requirements for special purpose equipment for counting, packing & handling soft gelatin capsules. "You have something to be proud of" were his words on visiting the plant.

 

ACG Worldwide has been a frequent recipient of 'Best Employer' award from the Maharashtra government.

 

The President of India lauded their efforts for incorporating physically challenged and under privileged persons into their organization. They were conferred the 'Outstanding Employer' award for the physically challenged.

 

The company's management was invited by the government to make a special presentation on employment policies at the Tripartite Labour Conference at Delhi consisting of public sector heads, union leaders & the government. It was rare honour for a private sector company.

 

 

Partners and Alliances

 

"In this new wave of technology, you can't do it all yourself, you have to form alliances."

- Carlos Slim Helu,

Mexican businessman, third richest in the world.

 

Glatt, IWKA, Honeywell, Brimrose, Alcan, Sarong, Proditec, Volpak are the eight companies they have formed partnership & alliances with. All established companies in their own right; they have contributed immensely to the value addition of ACG Worldwide. They act as representatives of these global players in the pharmaceutical industry in India, in a bid to make India proud on the world map.

 

Glatt

Fluidized bed systems is the pioneering product of Glatt.

 

 

IWKA

Suppliers of systems and machines for pharmaceutical industry, IWKA the biggest name in many other verticals too.

 

Honeywell

Aclar film, the star product of Honeywell is the key ingredient in blister packaging.

 

Brimrose

The final product quality check is facilitated due to PAT(Process Analytical Technology). A technology developed by Brimrose.

 

Alcan

Packshield is the alliance formed with Alcan, that aids in packaging of the various products.

 

Sarong

Sarong is a leading name in the machinery manufacturing & packaging materials industry.

 

Proditec

Their inspection systems products have helped in sorting & measurement of capsules.

 

Volpak

They are specialists in designing and manufacturing machines for flexible packages, cartoners and case packers.

 

News

 

ACG Worldwide participates in Pharmtech 2006

 

ACG Worldwide participated in Pharmtech Moscow, an exhibition held in Moscow, Russia from 20 – 23rd November 2006.

 

A range of engineering & consumable products that included Blister packing, capsule filling machines and different types of Capsules and Packaging films was displayed in this exhibition.

 

Legacy 6100 – the futuristic tabletting machine from Pam was inaugurated in grand style. The exhibition was a grand success

 

TROPAC wins the PACMACHINE 2006 award

 

Tropical Blister Packing machine – TROPAC, from Pampac Machines Private Limited won the PACMACHINE 2006 award.

The award function organized by the Indian Institute of packaging in the Leela Kempenski Hotel, Mumbai on 13th December 2006. The eminent jury for judging the entries consisted of Dr. S. D. Awale – Director NITIE, Mr. K. Murari – Addl. Director ERTL, Dr. K. G. Narayankhedkar – Director, VJTI & Mr. Rajeev Dhar – Director IIP.

 

Mr. Sandeep Kulkarni, VP - Pampac is seen receiving the award.

 

ACG Worldwide participates in Indiapack 2006

 

ACG Worldwide now caters to many sectors and businesses other than Pharmaceuticals. It participated in a non-pharma exhibition for the first time in Indiapack 2006. The exhibition was held in Mumbai, India from 11 – 14th December 2006.

 

On the display were the various barrier and flexible packaging films, online check weigher, special purpose cartooning machine “AT – Pac” and various samples of ranging from blisters & cartons to pouches showing our capability.

 

It won the second prize for “Technology in Packaging” at the Indiapack show for the machines exhibited in the stall.

 

 

PAM Pharmaceutical & Allied Machinery Company Limited

 

127, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, India.

 

Tel. No. : 91-22-2868 2650 / 2868 9109

Fax No. : 91-22-2868 3091

E-mail. : sales.pam@acg-world.com

 

Pam-Pac Machines Private Limited

 

127, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067, India.

 

Tel. No. : 91-22-2868 2650 / 2868 9109

Fax No. : 91-22-2868 3091

E-mail. : sales.pampac@acg-world.com

 

Pam Glatt Pharma Technologies Private Limited

 

Sr. No. 14,16, Jankar Estate, J. M. Compound, Mira - Bhayandar Rd., Kashimira, Thane District - 401 104, India.

 

Tel. No. : 91-22-2811 7770

Fax No. : 91-22-2811 7778

E-mail. : pamglatt@acg-world.com

 

Packshield

 

7, Prabhat Nagar, Jogeshwari (West), Mumbai - 400 102, India.

 

Tel. No. : 91-22-2679 1955 / 2678 9642

Fax No. : 91-22-2678 3244

E-mail. : sales.packshield@acg-world.com

 

 


 

CMT REPORT [Corruption, Money laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs. 44.09

UK Pound

1

Rs. 86.59

Euro

1

Rs. 57.92

 

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

8

PAID-UP CAPITAL

1~10

7

OPERATING SCALE

1~10

8

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

7

--PROFITABILIRY

1~10

8

--LIQUIDITY

1~10

7

--LEVERAGE

1~10

6

--RESERVES

1~10

7

--CREDIT LINES

1~10

8

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

66

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)                  Ownership background (20%)                         Payment record (10%)

Credit history (10%)                            Market trend (10%)                                             Operational size (10%)

 

 

RATING

STATUS

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

26-40

B

Unfavourable & favourable factors carry similar weight in credit consideration. Capability to overcome financial difficulties seems comparatively below average/normal.

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

Credit not recommended

 

 

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions